{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:37:39Z","timestamp":1793929059065,"version":"4.8.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Early clonal dominance may distinguish chronic myelomonocytic leukemia from other chronic myeloid neoplasms with similar gene mutations. Early dominance of TET2-mutated cells in the hematopoietic tissue promotes myeloid differentiation skewing toward the granulomonocytic line.<\/jats:p>","DOI":"10.1182\/blood-2012-06-440347","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T23:52:32Z","timestamp":1358207552000},"page":"2186-2198","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":268,"title":["Clonal architecture of chronic myelomonocytic leukemias"],"prefix":"10.1182","volume":"121","author":[{"given":"Rapha\u00ebl","family":"Itzykson","sequence":"first","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, University Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00e9matologie Biologique, H\u00f4pital Cochin, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"D\u00e9partement d'Immuno-H\u00e9matologie, Institut Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Renneville","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, CHRU of Lille, Lille, France"},{"name":"University of Lille Nord de France, Lille, France"},{"name":"Inserm, U837, Team 3, Cancer Research Institute of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Morabito","sequence":"additional","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, University Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, Biology and Pathology Center, CHRU of Lille, Lille, France"},{"name":"University of Lille Nord de France, Lille, France"},{"name":"Inserm, U837, Team 3, Cancer Research Institute of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Berthon","sequence":"additional","affiliation":[{"name":"University of Lille Nord de France, Lille, France"},{"name":"CHRU de Lille, Clinical hematology Unit, CHU Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[{"name":"H\u00f4pital Avicenne, Assistance Publique-H\u00f4pitaux de Paris, Service d\u2019H\u00e9matologie Clinique, University Paris XIII, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[{"name":"H\u00f4pital Avicenne, Assistance Publique-H\u00f4pitaux de Paris, Service d\u2019H\u00e9matologie Clinique, University Paris XIII, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Universit\u00e4tsklinikum \u2018Carl Gustav Carus' Dresden, 01307 Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gagey","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, Service de Chirurgie Orthop\u00e9dique, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rameau","sequence":"additional","affiliation":[{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Meurice","sequence":"additional","affiliation":[{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Or\u00e9ar","sequence":"additional","affiliation":[{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Delhommeau","sequence":"additional","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"UPMC Univ Paris 06, GRC n\u00b007, Groupe de Recherche Clinique sur les My\u00e9loprolif\u00e9rations Aigu\u00ebs et Chroniques MyPAC, F-75012, Paris, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00e9matologie et Immunologie Biologique, H\u00f4pital Saint-Antoine, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Inserm UMR985, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fontenay","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00e9matologie Biologique, H\u00f4pital Cochin, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris Descartes, Paris, France;"},{"name":"D\u00e9partement d'Immuno-H\u00e9matologie, Institut Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, University Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, University Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[{"name":"Inserm UMR1009, and"},{"name":"IFR54, Institut Gustave Roussy, Villejuif, France"},{"name":"Faculty of Medicine, University Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7381","key":"2019111816421993200_B1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer.","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"7330","key":"2019111816421993200_B2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and propagating cells in leukaemia.","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111816421993200_B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development.","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"issue":"12","key":"2019111816421993200_B4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia.","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111816421993200_B5","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers.","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"2019111816421993200_B6","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"issue":"14","key":"2019111816421993200_B7","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2010-10-311019","article-title":"Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.","volume":"118","author":"Jankowska","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111816421993200_B8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2011.08631.x","article-title":"Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.","volume":"153","author":"Bacher","year":"2011","journal-title":"Br J Haematol"},{"issue":"24","key":"2019111816421993200_B9","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"2019111816421993200_B10","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2019111816421993200_B11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood-2008-04-152157","article-title":"High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.","volume":"113","author":"Tyner","year":"2009","journal-title":"Blood"},{"issue":"7367","key":"2019111816421993200_B12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia.","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111816421993200_B13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2012.064048","article-title":"Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.","volume":"98","author":"Kar","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"2019111816421993200_B14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111816421993200_B15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/leu.2011.58","article-title":"Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.","volume":"25","author":"Abdel-Wahab","year":"2011","journal-title":"Leukemia"},{"issue":"7","key":"2019111816421993200_B16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms.","volume":"118","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"issue":"26","key":"2019111816421993200_B17","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes.","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"2019111816421993200_B18","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2009-08-236596","article-title":"Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.","volume":"115","author":"Beer","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111816421993200_B19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3324\/haematol.2011.045591","article-title":"Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.","volume":"96","author":"Stein","year":"2011","journal-title":"Haematologica"},{"issue":"15","key":"2019111816421993200_B20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"2019111816421993200_B21","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2011-05-352039","article-title":"Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.","volume":"118","author":"Braun","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111816421993200_B22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2006-10-054940","article-title":"The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.","volume":"110","author":"Dupont","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2019111816421993200_B23","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood-2010-12-324707","article-title":"Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.","volume":"118","author":"Pronier","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111816421993200_B24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","article-title":"Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.","volume":"14","author":"Kotecha","year":"2008","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111816421993200_B25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/leu.2008.265","article-title":"Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.","volume":"23","author":"Gaipa","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"2019111816421993200_B26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0301-472X(02)00903-7","article-title":"Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo.","volume":"30","author":"Ramshaw","year":"2002","journal-title":"Exp Hematol"},{"issue":"19","key":"2019111816421993200_B27","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood-2010-03-274704","article-title":"Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111816421993200_B28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes.","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"2019111816421993200_B29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","article-title":"Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.","volume":"152","author":"Loh","year":"2011","journal-title":"Br J Haematol"},{"issue":"4260","key":"2019111816421993200_B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations.","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"issue":"7330","key":"2019111816421993200_B31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"issue":"12","key":"2019111816421993200_B32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMc1108665","article-title":"Point mutations in myelodysplastic syndromes.","volume":"365","author":"Damm","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111816421993200_B33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2011.03.020","article-title":"Genetic interactions in cancer progression and treatment.","volume":"145","author":"Ashworth","year":"2011","journal-title":"Cell"},{"issue":"1","key":"2019111816421993200_B34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exphem.2010.09.008","article-title":"Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.","volume":"39","author":"Stein","year":"2011","journal-title":"Exp Hematol"},{"key":"2019111816421993200_B35","author":"Jan"},{"issue":"11","key":"2019111816421993200_B36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"issue":"7341","key":"2019111816421993200_B37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing.","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"issue":"5","key":"2019111816421993200_B38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2012.02.028","article-title":"Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm.","volume":"148","author":"Hou","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2019111816421993200_B39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cell.2009.04.057","article-title":"MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.","volume":"138","author":"Sarrazin","year":"2009","journal-title":"Cell"},{"issue":"5937","key":"2019111816421993200_B40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171461","article-title":"Hematopoietic cytokines can instruct lineage choice.","volume":"325","author":"Rieger","year":"2009","journal-title":"Science"},{"issue":"35","key":"2019111816421993200_B41","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","article-title":"Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.","volume":"108","author":"Ko","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111816421993200_B42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111816421993200_B43","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.leukres.2006.12.025","article-title":"Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.","volume":"31","author":"Elliott","year":"2007","journal-title":"Leuk Res"},{"issue":"17","key":"2019111816421993200_B44","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood-2011-12-376749","article-title":"Stem cell heterogeneity: implications for aging and regenerative medicine.","volume":"119","author":"Muller-Sieburg","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2019111816421993200_B45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1309\/FU04P779U310R3EE","article-title":"Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.","volume":"126","author":"Wang","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2019111816421993200_B46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/modpathol.2012.165","article-title":"Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.","volume":"26","author":"Boiocchi","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"2019111816421993200_B47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/12\/2186\/1364940\/2186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/12\/2186\/1364940\/2186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:42:39Z","timestamp":1574095359000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/12\/2186\/31473\/Clonal-architecture-of-chronic-myelomonocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,21]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,3,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-440347","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,21]]}}}